Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews
Ju‐Hong Min(Samsung (South Korea)), Marius Ringelstein(Medizinische Hochschule Hannover), Jiawei Wang(Qilu University of Technology), Carly Welsh, Patricia Lobo(Aecom (United Kingdom)), Marco Aurélio Lana–Peixoto(Humboldt-Universität zu Berlin), Marco Capobianco(Ospedale San Luigi Gonzaga), Gabrielle deFiebre, Dean M. Wingerchuk(WinnMed)
Cited by 10
Related Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
The clinical course of neuromyelitis optica (Devic’s syndrome)
|Neurology|1999|1.8k